FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Jens Overgaard

Research Profile

Living Beings

Disorders

Procedures

Physiology

Chemicals & Drugs

Concepts & Ideas

Geographic Areas

Denmark

Co-author Network

Publications

TOP 3
Simen Myhre; Jens Overgaard; Trine Tramm; Jan Alsner; Miriam R Aure; Anne-Lise Børresen-Dale; Mark S Carey; Bryan T Hennessy; Ole Christian Lingjaerde; Gordon B Mills; Therese Sørlie
Influence of DNA copy number and mRNA levels on the expression of breast cancer related proteins.
N M Lyhne; Jens Overgaard; Hanne Primdahl; Jens Ahm Sørensen; K Toustrup; J B B Jespersen; Jørgen Johansen; T H Jung; C A Kristensen; Karin Lambertsen; M C Alanin; Elo Andersen; M A Bruhn; M T Bruun; C Buchwald; Troels Bundgaard; A Christensen; Christian Godballe; Cai Grau
Waiting times for diagnosis and treatment of head and neck cancer in Denmark in 2010 compared to 1992 and 2002.
Brita Sørensen; Jens Overgaard; Niels Bassler
In response to the commentary 'Particle species dependence of cell survival relative biological effectiveness: Evident and not negligible' by Thomas Friedrich, Marco Durante & Michael Scholz.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Jens Overgaard (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Simen Myhre; Jens Overgaard; Trine Tramm; Jan Alsner; Miriam R Aure; Anne-Lise Børresen-Dale; Mark S Carey; Bryan T Hennessy; Ole Christian Lingjaerde; Gordon B Mills; Therese Sørlie
Influence of DNA copy number and mRNA levels on the expression of breast cancer related proteins.
Molecular oncology 2013;7(3):704-18.
2013: N M Lyhne; Jens Overgaard; Hanne Primdahl; Jens Ahm Sørensen; K Toustrup; J B B Jespersen; Jørgen Johansen; T H Jung; C A Kristensen; Karin Lambertsen; M C Alanin; Elo Andersen; M A Bruhn; M T Bruun; C Buchwald; Troels Bundgaard; A Christensen; Christian Godballe; Cai Grau
Waiting times for diagnosis and treatment of head and neck cancer in Denmark in 2010 compared to 1992 and 2002.
European journal of cancer (Oxford, England : 1990) 2013;49(7):1627-33.
2013: Brita Sørensen; Jens Overgaard; Niels Bassler
In response to the commentary 'Particle species dependence of cell survival relative biological effectiveness: Evident and not negligible' by Thomas Friedrich, Marco Durante & Michael Scholz.
Acta oncologica (Stockholm, Sweden) 2013;52(3):591.
2013: Emilia Wiechec; Eigil Kjeldsen; Jens Overgaard; Lise Lotte Hansen
Chromosome 1q25.3 copy number alterations in primary breast cancers detected by multiplex ligation-dependent probe amplification and allelic imbalance assays and its comparison with fluorescent in situ hybridization assays.
Cellular oncology (Dordrecht) 2013;36(2):113-20.
2013: Charlotte Rotbøl Bøje; Susanne O Dalton; Therese K Grønborg; Jørgen Johansen; Claus A Kristensen; Elo Andersen; Lisbeth Juhler Andersen; Hanne Primdahl; Jens Overgaard
The impact of comorbidity on outcome in 12 623 Danish head and neck cancer patients: a population based study from the DAHANCA database.
Acta oncologica (Stockholm, Sweden) 2013;52(2):285-93.
2013: Anja Pagh; Niclas Rubek; Thomas Vedtofte; Christian von Buchwald; Elo Andersen; Maria Andersen; Christian Godballe; Jørgen Johansen; Claus Andrup Kristensen; Matilde Lonka; Charlotte Duch Lynggaard; Jens Overgaard; Cai Grau
The value of routine follow-up after treatment for head and neck cancer. A national survey from DAHANCA.
Acta oncologica (Stockholm, Sweden) 2013;52(2):277-84.
2013: Trille Kjær; Maja Halgren Olsen; Jens Overgaard; Marianne Steding-Jessen; Charlotte Rotbøl Bøje; Else Ibfelt; Jørgen Johansen; Christoffer Johansen; Susanne Oksbjerg Dalton
Affiliation to the work market after curative treatment of head-and-neck cancer: a population-based study from the DAHANCA database.
Acta oncologica (Stockholm, Sweden) 2013;52(2):430-9.
2013: Christina D Lyngholm; Peer M Christiansen; TE Damsgaard; Jens Overgaard
Long-term follow-up of late morbidity, cosmetic outcome and body image after breast conserving therapy. A study from the Danish Breast Cancer Cooperative Group (DBCG).
Acta oncologica (Stockholm, Sweden) 2013;52(2):259-69.
2013: Simon Lønbro; Jens Overgaard; Ulrik Dalgas; Hanne Primdahl; Kristian Overgaard
Feasibility and efficacy of progressive resistance training and dietary supplements in radiotherapy treated head and neck cancer patients--the DAHANCA 25A study.
Acta oncologica (Stockholm, Sweden) 2013;52(2):310-8.
2013: Stefano Christian Londero; Jens Overgaard; Henrik Baymler Pedersen; Peter Ulrik Pedersen; Lars Bastholt; Jens Bentzen; Peer Christiansen; Thomas Frisch; Annelise Krogdahl; Christian Godballe
Papillary thyroid carcinoma in Denmark 1996-2008: an investigation of changes in incidence.
Cancer epidemiology 2013;37(1):e1-6.
2013: Trine Grantzau; Lene Mellemkjaer; Jens Overgaard
Second primary cancers after adjuvant radiotherapy in early breast cancer patients: a national population based study under the Danish Breast Cancer Cooperative Group (DBCG).
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2013;106(1):42-9.
2013: Martin Busk; F P D'Andrea; K V Hansen; Steen Jakobsen; J F Kallehauge; Leif Spange Mortensen; Marianne Nordsmark; Jens Overgaard; Torben Steiniche; J Theil; Michael R Horsman
PET hypoxia imaging with FAZA: reproducibility at baseline and during fractionated radiotherapy in tumour-bearing mice.
European journal of nuclear medicine and molecular imaging 2013;40(2):186-97.
2012: Michael R Horsman; Lise Saksø Mortensen; Martin Busk; Jørgen B Petersen; Jens Overgaard
Imaging hypoxia to improve radiotherapy outcome.
Nature reviews. Clinical oncology 2012;9(12):674-87.
2012: Pernille Lassen; Jens Overgaard
Scoring and classification of oropharyngeal carcinoma based on HPV-related p16-expression.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2012;105(2):269-70.
2012: Lise Saksø Mortensen; Marianne Nordsmark; Jan Alsner; Martin Busk; Steen Jakobsen; Jørgen Johansen; Jesper Kallehauge; Pernille Lassen; Henrik Petersen; Jørgen Petersen; Hanne Primdahl; Brita Sørensen; Jørn Theil; Kasper Toustrup; Jens Overgaard
FAZA PET/CT hypoxia imaging in patients with squamous cell carcinoma of the head and neck treated with radiotherapy: results from the DAHANCA 24 trial.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2012;105(1):14-20.
2012: Michael H Holzscheiter; Niels Bassler; Manjit Dosanjh; Brita Sørensen; Jens Overgaard
A community call for a dedicated radiobiological research facility to support particle beam cancer therapy.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2012;105(1):1-3.
2012: Filippo P D'Andrea; Michael R Horsman; Moustapha Kassem; Jorge S Burns; Akmal Safwat; Jens Overgaard
Tumour microenvironment and radiation response in sarcomas originating from tumourigenic human mesenchymal stem cells.
International journal of radiation biology 2012;88(6):457-65.
2012: Filippo P D'Andrea; Michael R Horsman; Moustapha Kassem; Jens Overgaard; Akmal Safwat
Tumourigenicity and radiation resistance of mesenchymal stem cells.
Acta oncologica (Stockholm, Sweden) 2012;51(5):669-79.
2012: Hanna R Mortensen; Jens Overgaard; Marie Overgaard; Lena Specht; Elo Andersen; Lisbeth Juhler Andersen; Jan F Evensen; Jørgen Johansen; Cai Grau
Prevalence and peak incidence of acute and late normal tissue morbidity in the DAHANCA 6&7 randomised trial with accelerated radiotherapy for head and neck cancer.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2012;103(1):69-75.
2012: Kasper Toustrup; Brita Sørensen; Jan Alsner; Jens Overgaard
Hypoxia gene expression signatures as prognostic and predictive markers in head and neck radiotherapy.
Seminars in radiation oncology 2012;22(2):119-27.
2012: Jens Overgaard; Harry Bartelink
Introduction: towards predicting outcome of radiotherapy-at last.
Seminars in radiation oncology 2012;22(2):87-90.
2012: Camilla Molich Hoff; Cai Grau; Jens Overgaard
Effect of smoking on oxygen delivery and outcome in patients treated with radiotherapy for head and neck squamous cell carcinoma--a prospective study.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2012;103(1):38-44.
2012: Kristine Bjørndal; Troels Bundgaard; Elo Andersen; Lisbeth Juhler Andersen; Preben Homøe; Jørgen Johansen; Claus A Kristensen; Annelise Krogdahl; Karin Lambertsen; Jens Overgaard; Hanne Primdahl; Christian Hjort Sørensen; MH Therkildsen; Christian Godballe
Salivary gland carcinoma in Denmark 1990-2005: outcome and prognostic factors. Results of the Danish Head and Neck Cancer Group (DAHANCA).
Oral oncology 2012;48(2):179-85.
2012: Kasper Toustrup; Carsten Wiuf; Jan Alsner; Pernille Lassen; Jens Overgaard; Brita Sørensen
Gene expression classifier predicts for hypoxic modification of radiotherapy with nimorazole in squamous cell carcinomas of the head and neck.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2012;102(1):122-9.
2011: Tomasz K Wojdacz; Søren Cold; Jens Overgaard; Britta B Thestrup; Lise L Hansen
No difference in the frequency of locus-specific methylation in the peripheral blood DNA of women diagnosed with breast cancer and age-matched controls.
Future oncology (London, England) 2011;7(12):1451-5.
2011: Camilla Molich Hoff; Jørgen Johansen; Pernille Lassen; Lisbeth Andersen; Jens Bentzen; Jesper Grau Eriksen; Jan F Evensen; Cai Grau; Hanne Sand Hansen; Marie Overgaard; Lena Specht; Jens Overgaard
Does transfusion improve the outcome for HNSCC patients treated with radiotherapy? - results from the randomized DAHANCA 5 and 7 trials.
Acta oncologica (Stockholm, Sweden) 2011;50(7):1006-14.
2011: Bekka O Christensen; Laura O Kettner; Jens Overgaard; TE Damsgaard
Long-term evaluation of postmastectomy breast reconstruction.
Acta oncologica (Stockholm, Sweden) 2011;50(7):1053-61.
2011: Brita Sørensen; Anne Vestergaard; Jens Overgaard; Lars Hjorth Præstegaard
Dependence of cell survival on instantaneous dose rate of a linear accelerator.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2011;101(1):223-5.
2011: Brita Sørensen; Jens Overgaard; Niels Bassler
In vitro RBE-LET dependence for multiple particle types.
Acta oncologica (Stockholm, Sweden) 2011;50(6):757-62.
2011: Jens Overgaard
Advancing radiation oncology through scientific publication--100 volumes of Radiotherapy and Oncology.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2011;100(1):1-6.
2011: Kristine Bjørndal; Troels Bundgaard; Elo Andersen; Lisbeth Juhler Andersen; Preben Homøe; Jørgen Johansen; Claus A Kristensen; Annelise Krogdahl; Karin Lambertsen; Jens Overgaard; Hanne Primdahl; Christian Hjort Sørensen; MH Therkildsen; Christian Godballe
Salivary gland carcinoma in Denmark 1990-2005: a national study of incidence, site and histology. Results of the Danish Head and Neck Cancer Group (DAHANCA).
Oral oncology 2011;47(7):677-82.
2011: Jens Overgaard
Hypoxic modification of radiotherapy in squamous cell carcinoma of the head and neck--a systematic review and meta-analysis.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2011;100(1):22-32.
2011: Pernille Lassen; Jens Overgaard; Marie Overgaard; Lena Specht; Marianne Hamilton Therkildsen; Benedicte P Ulhøi; Elo Andersen; Lisbeth Juhler Andersen; Jesper Grau Eriksen; Cai Grau; Jørgen Johansen; Annelise Krogdahl
The influence of HPV-associated p16-expression on accelerated fractionated radiotherapy in head and neck cancer: evaluation of the randomised DAHANCA 6&7 trial.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2011;100(1):49-55.
2011: Lise Saksø Mortensen; Marianne Nordsmark; Jens Overgaard; Jørn Theil; Martin Busk; Steen Jakobsen; Michael R Horsman
Accessing radiation response using hypoxia PET imaging and oxygen sensitive electrodes: a preclinical study.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2011;99(3):418-23.
2011: Filippo P D'Andrea; Laurant Gautier; Moustapha Kassem; Jens Overgaard; Akmal Safwat; Michael R Horsman
Cancer stem cell overexpression of nicotinamide N-methyltransferase enhances cellular radiation resistance.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2011;99(3):373-8.
2011: Martin Busk; Michael R Horsman; Steen Jakobsen; Wolfgang Mueller-Klieser; Torben Steiniche; Stefan Walenta; Jens Overgaard
Inhibition of tumor lactate oxidation: consequences for the tumor microenvironment.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2011;99(3):404-11.
2011: Emilia Wiechec; Carsten Wiuf; Jens Overgaard; Lise Lotte Hansen
High-resolution melting analysis for mutation screening of RGSL1, RGS16, and RGS8 in breast cancer.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2011;20(2):397-407.
2011: Morten Busk; Kasper Toustrup; Boe Sandahl Sørensen; Jan Alsner; Michael R Horsman; Steen Jakobsen; Jens Overgaard
In vivo identification and specificity assessment of mRNA markers of hypoxia in human and mouse tumors.
BMC cancer 2011;11():63.
2011: Camilla Molich Hoff; Hanne Sand Hansen; Marie Overgaard; Cai Grau; Jørgen Johansen; Jens Bentzen; Jens Overgaard
The importance of haemoglobin level and effect of transfusion in HNSCC patients treated with radiotherapy--results from the randomized DAHANCA 5 study.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2011;98(1):28-33.
2010: C M Sgrò; Jens Overgaard; Torsten Nygaard Kristensen; K A Mitchell; F E Cockerell; Ary A Hoffmann
A comprehensive assessment of geographic variation in heat tolerance and hardening capacity in populations of Drosophila melanogaster from eastern Australia.
Journal of evolutionary biology 2010;23(11):2484-93.
2010: Birgitte Vrou Offersen; Marianne M Knap; Michael R Horsman; Jan Verheijen; roeland hanemaaijer; Jens Overgaard
Matrix metalloproteinase-9 measured in urine from bladder cancer patients is an independent prognostic marker of poor survival.
Acta oncologica (Stockholm, Sweden) 2010;49(8):1283-7.
2010: Isabel Nawroth; Jan Alsner; Mark A Behlke; Flemming Besenbacher; Jens Overgaard; Kenneth A Howard; Jørgen Kjems
Intraperitoneal administration of chitosan/DsiRNA nanoparticles targeting TNFα prevents radiation-induced fibrosis.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2010;97(1):143-8.
2010: Lise Saksø Mortensen; Simon Buus; Marianne Nordsmark; Lise Bentzen; Ole Lajord Munk; Susanne Keiding; Jens Overgaard
Identifying hypoxia in human tumors: A correlation study between 18F-FMISO PET and the Eppendorf oxygen-sensitive electrode.
Acta oncologica (Stockholm, Sweden) 2010;49(7):934-40.
2010: Morten Busk; Ole Lajord Munk; Steen Jakobsen; Tobias Wang; Marianne Skals; Torben Steiniche; Michael R Horsman; Jens Overgaard
Assessing hypoxia in animal tumor models based on pharmocokinetic analysis of dynamic FAZA PET.
Acta oncologica (Stockholm, Sweden) 2010;49(7):922-33.
2010: Cai Grau; Dag Rune Olsen; Jens Overgaard; Morten Høyer; Jacob Christian Lindegaard; Ludvig Paul Muren
Biology-guided adaptive radiation therapy - presence or future?
Acta oncologica (Stockholm, Sweden) 2010;49(7):884-7.
2010: Boe Sandahl Sørensen; Kasper Toustrup; Michael R Horsman; Jens Overgaard; Jan Alsner
Identifying pH independent hypoxia induced genes in human squamous cell carcinomas in vitro.
Acta oncologica (Stockholm, Sweden) 2010;49(7):895-905.
2010: Jens Overgaard; Bidhu Kaylan Mohanti; Naseem Begum; Rubina Ali; Jai Prakash Agarwal; Maire Kuddu; Suman Bhasker; Hideo Tatsuzaki; Cai Grau
Five versus six fractions of radiotherapy per week for squamous-cell carcinoma of the head and neck (IAEA-ACC study): a randomised, multicentre trial.
The lancet oncology 2010;11(6):553-60.
2010: Jesper Grau Eriksen; Pernille Lassen; Jens Overgaard
Do all patients with head and neck cancer benefit from radiotherapy and concurrent cetuximab?
The lancet oncology 2010;11(4):312-3.
2010: Kristina Pedersen; Emilia Wiechec; Bo E Madsen; Jens Overgaard; Lise Lotte Hansen
A simple way to evaluate self-designed probes for tumor specific Multiplex Ligation-dependent Probe Amplification (MLPA).
BMC research notes 2010;3():179.
2010: Pernille Lassen; Jesper Grau Eriksen; Stephen Hamilton-Dutoit; Trine Tramm; Jan Alsner; Jens Overgaard
HPV-associated p16-expression and response to hypoxic modification of radiotherapy in head and neck cancer.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2010;94(1):30-5.
2009: Morten Busk; Michael R Horsman; Steen Jakobsen; Kim V Hansen; Johan Bussink; Albert J van der Kogel; Jens Overgaard
Can hypoxia-PET map hypoxic cell density heterogeneity accurately in an animal tumor model at a clinically obtainable image contrast?
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2009;92(3):429-36.
2009: Brita Sørensen; Michael R Horsman; Henrik Vorum; Bent Honoré; Jens Overgaard; Jan Alsner
Proteins upregulated by mild and severe hypoxia in squamous cell carcinomas in vitro identified by proteomics.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2009;92(3):443-9.
2009: Jens Overgaard
Chemoradiotherapy of head and neck cancer--can the bumble bee fly?
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2009;92(1):1-3.
2009: Pernille Lassen; Jesper Grau Eriksen; Stephen Hamilton-Dutoit; Trine Tramm; Jan Alsner; Jens Overgaard
Effect of HPV-associated p16INK4A expression on response to radiotherapy and survival in squamous cell carcinoma of the head and neck.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(12):1992-8.
2009: Birgitte V Offersen; Marie Overgaard; Niels Kroman; Jens Overgaard
Accelerated partial breast irradiation as part of breast conserving therapy of early breast carcinoma: a systematic review.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2009;90(1):1-13.
2009: Marianne Kyndi; Marie Overgaard; Hanne Melgaard Nielsen; Flemming Brandt Sørensen; Helle Knudsen; Jens Overgaard
High local recurrence risk is not associated with large survival reduction after postmastectomy radiotherapy in high-risk breast cancer: a subgroup analysis of DBCG 82 b&c.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2009;90(1):74-9.
2008: Emilia Wiechec; Jens Overgaard; Lise Lotte Hansen
A fragile site within the HPC1 region at 1q25.3 affecting RGS16, RGSL1, and RGSL2 in human breast carcinomas.
Genes, chromosomes & cancer 2008;47(9):766-80.
2008: Morten Busk; Michael R Horsman; Paul E.G. Kristjansen; Albert J van der Kogel; Johan Bussink; Jens Overgaard
Aerobic glycolysis in cancers: implications for the usability of oxygen-responsive genes and fluorodeoxyglucose-PET as markers of tissue hypoxia.
International journal of cancer. Journal international du cancer 2008;122(12):2726-34.
2008: Jan Alsner; Christian Nicolaj Andreassen; Jens Overgaard
Genetic markers for prediction of normal tissue toxicity after radiotherapy.
Seminars in radiation oncology 2008;18(2):126-35.
2008: Jørgen Johansen; Simon Buus; Annika Loft; Susanne Keiding; Marie Overgaard; Hanne Sand Hansen; Cai Grau; Troels Bundgaard; Jørgen Kirkegaard; Jens Overgaard
Prospective study of 18FDG-PET in the detection and management of patients with lymph node metastases to the neck from an unknown primary tumor. Results from the DAHANCA-13 study.
Head & neck 2008;30(4):471-8.
2008: Marianne Kyndi; Flemming Brandt Sørensen; Helle Knudsen; Marie Overgaard; Hanne Melgaard Nielsen; Jens Overgaard
Estrogen receptor, progesterone receptor, HER-2, and response to postmastectomy radiotherapy in high-risk breast cancer: the Danish Breast Cancer Cooperative Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(9):1419-26.
2008: Morten Busk; Michael R Horsman; Steen Jakobsen; Susanne Keiding; Albert J van der Kogel; Johan Bussink; Jens Overgaard
Imaging hypoxia in xenografted and murine tumors with 18F-fluoroazomycin arabinoside: a comparative study involving microPET, autoradiography, PO2-polarography, and fluorescence microscopy.
International journal of radiation oncology, biology, physics 2008;70(4):1202-12.
2008: Olaug Kristin Rødningen; Anne-Lise Børresen-Dale; Jan Alsner; Trevor Hastie; Jens Overgaard
Radiation-induced gene expression in human subcutaneous fibroblasts is predictive of radiation-induced fibrosis.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2008;86(3):314-20.
2008: Morten Busk; Michael R Horsman; Jens Overgaard
Resolution in PET hypoxia imaging: voxel size matters.
Acta oncologica (Stockholm, Sweden) 2008;47(7):1201-10.
2008: Bo Eskerod Madsen; Eliana Marisa Ramos; Mathieu Boulard; Katarzyna Duda; Jens Overgaard; Marianne Nordsmark; Carsten Wiuf; Lise Lotte Hansen
Germline mutation in RNASEL predicts increased risk of head and neck, uterine cervix and breast cancer.
PloS one 2008;3(6):e2492.
2008: Birgitte Vrou Offersen; Jan Alsner; Karen Ege Olsen; Rikke Riisbro; Nils Brünner; Flemming Brandt Sørensen; Boe Sandahl Sorensen; Birgitte Olrik Schlemmer; Jens Overgaard
A comparison among HER2, TP53, PAI-1, angiogenesis, and proliferation activity as prognostic variables in tumours from 408 patients diagnosed with early breast cancer.
Acta oncologica (Stockholm, Sweden) 2008;47(4):618-32.
2008: M Kyndi; Flemming Brandt Sørensen; H Knudsen; Jan Alsner; Marie Overgaard; Hanne Melgaard Nielsen; Jens Overgaard
Impact of BCL2 and p53 on postmastectomy radiotherapy response in high-risk breast cancer. A subgroup analysis of DBCG82 b&c.
Acta oncologica (Stockholm, Sweden) 2008;47(4):608-17.
2008: Jan Alsner; Vibeke Jensen; Marianne Kyndi; Birgitte Vrou Offersen; Phuong Vu; Anne-Lise Børresen-Dale; Jens Overgaard
A comparison between p53 accumulation determined by immunohistochemistry and TP53 mutations as prognostic variables in tumours from breast cancer patients.
Acta oncologica (Stockholm, Sweden) 2008;47(4):600-7.
2008: M Kyndi; Flemming Brandt Sørensen; H Knudsen; Marie Overgaard; Hanne Melgaard Nielsen; J Andersen; Jens Overgaard
Tissue microarrays compared with whole sections and biochemical analyses. A subgroup analysis of DBCG 82 b&c.
Acta oncologica (Stockholm, Sweden) 2008;47(4):591-9.
2008: Mette Cathrine Lauridsen; Marie Overgaard; Jens Overgaard; I B Hessov; Peer Cristiansen
Shoulder disability and late symptoms following surgery for early breast cancer.
Acta oncologica (Stockholm, Sweden) 2008;47(4):569-75.
2008: Anni R Jensen; Anders Husted Madsen; Jens Overgaard
Trends in breast cancer during three decades in Denmark: stage at diagnosis, surgical management and survival.
Acta oncologica (Stockholm, Sweden) 2008;47(4):537-44.
2008: Marianne Kyndi; Flemming Brandt Sørensen; Helle Knudsen; Jan Alsner; Marie Overgaard; Hanne Melgaard Nielsen; Jens Overgaard
Carbonic anhydrase IX and response to postmastectomy radiotherapy in high-risk breast cancer: a subgroup analysis of the DBCG82 b and c trials.
Breast cancer research : BCR 2008;10(2):R24.
2008: Anders Husted Madsen; Anni R Jensen; Peer Christiansen; Jens Peter Garne; Søren Cold; Marianne Ewertz; Jens Overgaard
Does the introduction of sentinel node biopsy increase the number of node positive patients with early breast cancer? A population based study form the Danish Breast Cancer Cooperative Group.
Acta oncologica (Stockholm, Sweden) 2008;47(2):239-47.
2008: Niels Bassler; Jan Alsner; Gerd Beyer; John J DeMarco; Michael Doser; Dragan Hajdukovic; Oliver Hartley; Keisuke S Iwamoto; Oliver Jäkel; Helge V Knudsen; Sandra Kovacevic; Søren Pape Møller; Jens Overgaard; Jørgen B Petersen; Timothy D Solberg; Brita Sørensen; Sanja Vranjes; Bradly G Wouters; Michael H Holzscheiter
Antiproton radiotherapy.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2008;86(1):14-9.
2008: Slavka Lukacova; Boe Sandahl Sørensen; Jan Alsner; Jens Overgaard; Michael R Horsman
The impact of hypoxia on the activity of lactate dehydrogenase in two different pre-clinical tumour models.
Acta oncologica (Stockholm, Sweden) 2008;47(5):941-7.
2007: Jens Overgaard
Hypoxic radiosensitization: adored and ignored.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(26):4066-74.
2007: Michael R Horsman; Jens Overgaard
Hyperthermia: a potent enhancer of radiotherapy.
Clinical oncology (Royal College of Radiologists (Great Britain)) 2007;19(6):418-26.
2007: Anni R Jensen; Hanne Marie Nellemann; Jens Overgaard
Tumor progression in waiting time for radiotherapy in head and neck cancer.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2007;84(1):5-10.
2007: Jesper Grau Eriksen; Jens Overgaard
Lack of prognostic and predictive value of CA IX in radiotherapy of squamous cell carcinoma of the head and neck with known modifiable hypoxia: an evaluation of the DAHANCA 5 study.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2007;83(3):383-8.
2007: Brita Sørensen; Jan Alsner; Jens Overgaard; Michael R Horsman
Hypoxia induced expression of endogenous markers in vitro is highly influenced by pH.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2007;83(3):362-6.
2007: Jan Alsner; Olaug Kristin Rødningen; Jens Overgaard
Differential gene expression before and after ionizing radiation of subcutaneous fibroblasts identifies breast cancer patients resistant to radiation-induced fibrosis.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2007;83(3):261-6.
2007: Marianne Nordsmark; Jesper Grau Eriksen; Val Gebski; Jan Alsner; Michael R Horsman; Jens Overgaard
Differential risk assessments from five hypoxia specific assays: The basis for biologically adapted individualized radiotherapy in advanced head and neck cancer patients.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2007;83(3):389-97.
2007: Jan Thøgersen; Cindy S Knudsen; Alice Maetzke; Svend J Knak Jensen; Søren Rud Keiding; Jan Alsner; Jens Overgaard
Reproductive death of cancer cells induced by femtosecond laser pulses.
International journal of radiation biology 2007;83(5):289-99.
2007: Birgitte Vrou Offersen; Per Pfeiffer; Peter A Andreasen; Jens Overgaard
Urokinase plasminogen activator and plasminogen activator inhibitor type-1 in nonsmall-cell lung cancer: relation to prognosis and angiogenesis.
Lung cancer (Amsterdam, Netherlands) 2007;56(1):43-50.
2007: Marie Overgaard; Hanne Melgaard Nielsen; Jens Overgaard
Is the benefit of postmastectomy irradiation limited to patients with four or more positive nodes, as recommended in international consensus reports? A subgroup analysis of the DBCG 82 b&c randomized trials.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2007;82(3):247-53.
2007: Birgitte Vrou Offersen; Rikke Riisbro; Ann Knoop; Nils Brünner; Jens Overgaard
Lack of association between level of Plasminogen Activator Inhibitor-1 and estimates of tumor angiogenesis in early breast cancer.
Acta oncologica (Stockholm, Sweden) 2007;46(6):782-91.
2007: Jørgen Johansen; Jens Overgaard; Marie Overgaard
Effect of adjuvant systemic treatment on cosmetic outcome and late normal-tissue reactions after breast conservation.
Acta oncologica (Stockholm, Sweden) 2007;46(4):525-33.
2007: Marianne M Knap; Søren M Bentzen; Jens Overgaard
Late neurological complications after irradiation of malignant tumors of the testis.
Acta oncologica (Stockholm, Sweden) 2007;46(4):497-503.
2006: Christian Nicolaj Andreassen; Jan Alsner; Marie Overgaard; Flemming Brandt Sørensen; Jens Overgaard
Risk of radiation-induced subcutaneous fibrosis in relation to single nucleotide polymorphisms in TGFB1, SOD2, XRCC1, XRCC3, APEX and ATM--a study based on DNA from formalin fixed paraffin embedded tissue samples.
International journal of radiation biology 2006;82(8):577-86.
2006: Slavka Lukacova; Jens Overgaard; Jan Alsner; Michael R Horsman
Strain and tumour specific variations in the effect of hypoxia on osteopontin levels in experimental models.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2006;80(2):165-71.
2006: Marianne Nordsmark; Juliette A Loncaster; Christina Aquino-Parsons; Shu-Chuan Chou; Val Gebski; Catharine West; Jens Lindegaard; Hanne Havsteen; Susan E Davidson; Robin Hunter; James Raleigh; Jens Overgaard
The prognostic value of pimonidazole and tumour pO2 in human cervix carcinomas after radiation therapy: a prospective international multi-center study.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2006;80(2):123-31.
2006: Alice Ho; David P Atencio; Sheila Peters; Richard G Stock; Silvia C Formenti; Jamie A. Cesaretti; Sheryl Green; Bruce G Haffty; Karen Drumea; Larisa Leitzin; Abraham Kuten; David Azria; Mahmut Ozsahin; Jens Overgaard; Christian Nicolaj Andreassen; Cynthia S Trop; Janelle Park; Barry S Rosenstein
Genetic predictors of adverse radiotherapy effects: the Gene-PARE project.
International journal of radiation oncology, biology, physics 2006;65(3):646-55.
2006: Hanne Melgaard Nielsen; Marie Overgaard; Cai Grau; Anni R Jensen; Jens Overgaard
Study of failure pattern among high-risk breast cancer patients with or without postmastectomy radiotherapy in addition to adjuvant systemic therapy: long-term results from the Danish Breast Cancer Cooperative Group DBCG 82 b and c randomized studies.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(15):2268-75.
2006: Hanne Melgaard Nielsen; Marie Overgaard; Cai Grau; Anni R Jensen; Jens Overgaard
Loco-regional recurrence after mastectomy in high-risk breast cancer--risk and prognosis. An analysis of patients from the DBCG 82 b&c randomization trials.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2006;79(2):147-55.
2006: Peter Isager; G Engholm; Jens Overgaard; H Storm
Uveal and conjunctival malignant melanoma in denmark 1943-97: observed and relative survival of patients followed through 2002.
Ophthalmic epidemiology 2006;13(2):85-96.
2006: Christian Nicolaj Andreassen; Jens Overgaard; Jan Alsner; Marie Overgaard; Carsten Herskind; Jamie A. Cesaretti; David P Atencio; Sheryl Green; Silvia C Formenti; Richard G Stock; Barry S Rosenstein
ATM sequence variants and risk of radiation-induced subcutaneous fibrosis after postmastectomy radiotherapy.
International journal of radiation oncology, biology, physics 2006;64(3):776-83.
2006: Michael R Horsman; Thomas Nielsen; Leif Østergaard; Jens Overgaard
Radiation administered as a large single dose or in a fractionated schedule: Role of the tumour vasculature as a target for influencing response.
Acta oncologica (Stockholm, Sweden) 2006;45(7):876-80.
2006: Marianne Kyndi; Jan Alsner; Lise Lotte Hansen; Flemming Brandt Sørensen; Jens Overgaard
LOH rather than genotypes of TP53 codon 72 is associated with disease-free survival in primary breast cancer.
Acta oncologica (Stockholm, Sweden) 2006;45(5):602-9.
2006: Peter Isager; Niels Ehlers; Steen F Urbak; Jens Overgaard
Visual outcome, local tumour control, and eye preservation after 106Ru/Rh brachytherapy for choroidal melanoma.
Acta oncologica (Stockholm, Sweden) 2006;45(3):285-93.
2006: Hanne Primdahl; Anni Linnet Nielsen; Susanne Larsen; Elo Andersen; Merete Ipsen; Christel Lajer; Lene Weber Vestermark; Lisbeth Juhler Andersen; Hanne Sand Hansen; Marie Overgaard; Jens Overgaard; Cai Grau
Changes from 1992 to 2002 in the pretreatment delay for patients with squamous cell carcinoma of larynx or pharynx: a Danish nationwide survey from DAHANCA.
Acta oncologica (Stockholm, Sweden) 2006;45(2):156-61.
2005: Slavka Lukacova; Azza A Khalil; Jens Overgaard; Jan Alsner; Michael R Horsman
Relationship between radiobiological hypoxia in a C3H mouse mammary carcinoma and osteopontin levels in mouse serum.
International journal of radiation biology 2005;81(12):937-44.
2005: Olaug Kristin Rødningen; Jens Overgaard; Jan Alsner; Trevor Hastie; Anne-Lise Børresen-Dale
Microarray analysis of the transcriptional response to single or multiple doses of ionizing radiation in human subcutaneous fibroblasts.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2005;77(3):231-40.
2005: Ann Knoop; Helle Knudsen; Eva Balslev; Birgitte Bruun Rasmussen; Jens Overgaard; Kirsten Vang Nielsen; Andreas Schonau; Katrín Gunnarsdóttir; Karen E Olsen; Henning Mouridsen; Bent Ejlertsen
retrospective analysis of topoisomerase IIa amplifications and deletions as predictive markers in primary breast cancer patients randomly assigned to cyclophosphamide, methotrexate, and fluorouracil or cyclophosphamide, epirubicin, and fluorouracil: Danish Breast Cancer Cooperative Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(30):7483-90.
2005: Jens Overgaard; Jesper Grau Eriksen; Marianne Nordsmark; Jan Alsner; Michael R Horsman
Plasma osteopontin, hypoxia, and response to the hypoxia sensitiser nimorazole in radiotherapy of head and neck cancer: results from the DAHANCA 5 randomised double-blind placebo-controlled trial.
The lancet oncology 2005;6(10):757-64.
2005: Marianne Nordsmark; Søren M Bentzen; Volker Rudat; David M. Brizel; Eric Lartigau; Peter Stadler; Axel Becker; Markus Adam; Michael Molls; Jürgen Dunst; David J Terris; Jens Overgaard
Prognostic value of tumor oxygenation in 397 head and neck tumors after primary radiation therapy. An international multi-center study.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2005;77(1):18-24.
2005: Hanne Melgaard Nielsen; Jens Overgaard; Cai Grau; Jens Juul Christensen; Marie Overgaard
Audit of the radiotherapy in the DBCG 82 b&c trials--a validation study of the 1,538 patients randomised to postmastectomy radiotherapy.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2005;76(3):285-92.
2005: Brita Sørensen; Jing Hao; Jens Overgaard; Henrik Vorum; Bent Honoré; Jan Alsner; Michael R Horsman
Influence of oxygen concentration and pH on expression of hypoxia induced genes.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2005;76(2):187-93.
2005: Peter Isager; A Østerlind; G Engholm; Steffen Heegaard; Jens Lindegaard; Jens Overgaard; Hans H Storm
Uveal and conjunctival malignant melanoma in Denmark, 1943-97: incidence and validation study.
Ophthalmic epidemiology 2005;12(4):223-32.
2005: Jesper Grau Eriksen; Jan Alsner; Torben Steiniche; Jens Overgaard
The possible role of TP53 mutation status in the treatment of squamous cell carcinomas of the head and neck (HNSCC) with radiotherapy with different overall treatment times.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2005;76(2):135-42.
2005: Christian Nicolaj Andreassen; Jan Alsner; Jens Overgaard; Carsten Herskind; Jo Haviland; Roger Owen; Janis Homewood; Judith M Bliss; John Yarnold
TGFB1 polymorphisms are associated with risk of late normal tissue complications in the breast after radiotherapy for early breast cancer.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2005;75(1):18-21.
2005: Jens Overgaard
Radiotherapy and Oncology comes of age.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2005;75(1):1-5.
2005: Lise Bentzen; Peter Vestergaard-Poulsen; Thomas Nielsen; Jens Overgaard; Atle Bjørnerud; Karen Briley-Saebø; Michael R Horsman; Leif Ostergaard
Intravascular contrast agent-enhanced MRI measuring contrast clearance and tumor blood volume and the effects of vascular modifiers in an experimental tumor.
International journal of radiation oncology, biology, physics 2005;61(4):1208-15.
2005: Jesper Grau Eriksen; Torben Steiniche; Jens Overgaard
The influence of epidermal growth factor receptor and tumor differentiation on the response to accelerated radiotherapy of squamous cell carcinomas of the head and neck in the randomized DAHANCA 6 and 7 study.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2005;74(2):93-100.
2005: Jesper Grau Eriksen; Torben Steiniche; Jens Overgaard
The role of epidermal growth factor receptor and E-cadherin for the outcome of reduction in the overall treatment time of radiotherapy of supraglottic larynx squamous cell carcinoma.
Acta oncologica (Stockholm, Sweden) 2005;44(1):50-8.
2004: Peter Isager; Niels Ehlers; Jens Overgaard
Prognostic factors for survival after enucleation for choroidal and ciliary body melanomas.
Acta ophthalmologica Scandinavica 2004;82(5):517-25.
2004: Peter Isager; Niels Ehlers; Jens Overgaard
Have choroidal and ciliary body melanomas changed during the period 1955-2000?
Acta ophthalmologica Scandinavica 2004;82(5):509-16.
2004: Jesper Grau Eriksen; Torben Steiniche; Helmer Søgaard; Jens Overgaard
Expression of integrins and E-cadherin in squamous cell carcinomas of the head and neck.
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 2004;112(9):560-8.
2004: Christian Nicolaj Andreassen; Flemming Brandt Sørensen; Jens Overgaard; Jan Alsner
Optimisation and validation of methods to assess single nucleotide polymorphisms (SNPs) in archival histological material.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2004;72(3):351-6.
2004: Jesper Grau Eriksen; Francesca M Buffa; Jan Alsner; Torben Steiniche; Søren M Bentzen; Jens Overgaard
Molecular profiles as predictive marker for the effect of overall treatment time of radiotherapy in supraglottic larynx squamous cell carcinomas.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2004;72(3):275-82.
2004: Akmal Safwat; Ninna Aggerholm; Ivan M Roitt; Jens Overgaard; Marianne Hokland
Tumour burden and interleukin-2 dose affect the interaction between low-dose total body irradiation and interleukin 2.
European journal of cancer (Oxford, England : 1990) 2004;40(9):1412-7.
2004: Michael R Horsman; Jens Overgaard
Preclinical studies on how to deal with patient intolerance to nicotinamide and carbogen.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2004;70(3):301-9.
2004: Jesper Grau Eriksen; Torben Steiniche; Jon Askaa; Jan Alsner; Jens Overgaard
The prognostic value of epidermal growth factor receptor is related to tumor differentiation and the overall treatment time of radiotherapy in squamous cell carcinomas of the head and neck.
International journal of radiation oncology, biology, physics 2004;58(2):561-6.
2004: Anni R Jensen; Jens Peter Garne; Hans H Storm; Gerda Engholm; Torgil R Möller; Jens Overgaard
Does stage at diagnosis explain the difference in survival after breast cancer in Denmark and Sweden?
Acta oncologica (Stockholm, Sweden) 2004;43(8):719-26.
2004: Lars Vendelbo Johansen; Cai Grau; Jens Overgaard
Nodal control and surgical salvage after primary radiotherapy in 1782 patients with laryngeal and pharyngeal carcinoma.
Acta oncologica (Stockholm, Sweden) 2004;43(5):486-94.
2004: Marianne Nordsmark; Jens Overgaard
Tumor hypoxia is independent of hemoglobin and prognostic for loco-regional tumor control after primary radiotherapy in advanced head and neck cancer.
Acta oncologica (Stockholm, Sweden) 2004;43(4):396-403.
2004: Karen E Olsen; Helle Knudsen; Birgitte Bruun Rasmussen; Eva Balslev; Ann Knoop; Bent Ejlertsen; Kirsten Vang Nielsen; Andreas Schönau; Jens Overgaard
Amplification of HER2 and TOP2A and deletion of TOP2A genes in breast cancer investigated by new FISH probes.
Acta oncologica (Stockholm, Sweden) 2004;43(1):35-42.
2003: Birgitte Vrou Offersen; Flemming Brandt Sørensen; Ann Knoop; Jens Overgaard
The prognostic relevance of estimates of proliferative activity in early breast cancer.
Histopathology 2003;43(6):573-82.
2003: Christian Nicolaj Andreassen; Jan Alsner; Marie Overgaard; Jens Overgaard
Prediction of normal tissue radiosensitivity from polymorphisms in candidate genes.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2003;69(2):127-35.
2003: Birgitte Vrou Offersen; Boye Nielsen; Gunilla Høyer-Hansen; Fritz Rank; Stephen Hamilton-Dutoit; Jens Overgaard; Peter A Andreasen
The myofibroblast is the predominant plasminogen activator inhibitor-1-expressing cell type in human breast carcinomas.
The American journal of pathology 2003;163(5):1887-99.
2003: Jens Overgaard; Hanne Sand Hansen; Lena Specht; Marie Overgaard; Cai Grau; Elo Andersen; Jens Bentzen; Lars Bastholt; Olfred Hansen; Jørgen Johansen; Lisbeth Andersen; Jan F Evensen
Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6 and 7 randomised controlled trial.
Lancet 2003;362(9388):933-40.
2003: Cai Grau; Lars Vendelbo Johansen; Hanne Sand Hansen; Elo Andersen; Christian Godballe; Lisbeth Juhler Andersen; Jesper Hald; Henrik Møller; Marie Overgaard; Lars Bastholt; Ole Greisen; Grethe Harbo; Olfred Hansen; Jens Overgaard
Salvage laryngectomy and pharyngocutaneous fistulae after primary radiotherapy for head and neck cancer: a national survey from DAHANCA.
Head & neck 2003;25(9):711-6.
2003: A R Jensena; Marianne Ewertz; Søren Cold; Hans H Storm; Jens Overgaard
Time trends and regional differences in registration, stage distribution, surgical management and survival of breast cancer in Denmark.
European journal of cancer (Oxford, England : 1990) 2003;39(12):1783-93.
2003: Akmal Safwat; Ninna Aggerholm; Ivan M Roitt; Jens Overgaard; Marianne Hokland
Low-dose total body irradiation augments the therapeutic effect of interleukin-2 in a mouse model for metastatic malignant melanoma.
Journal of experimental therapeutics & oncology 2003;3(4):161-8.
2003: Lise Bentzen; Susanne Keiding; Marianne Nordsmark; Lise Falborg; Søren B Hansen; Johnny Keller; Ole Steen Nielsen; Jens Overgaard
Tumour oxygenation assessed by 18F-fluoromisonidazole PET and polarographic needle electrodes in human soft tissue tumours.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2003;67(3):339-44.
2003: Birgitte Vrou Offersen; Michael Borre; Jens Overgaard
Quantification of angiogenesis as a prognostic marker in human carcinomas: a critical evaluation of histopathological methods for estimation of vascular density.
European journal of cancer (Oxford, England : 1990) 2003;39(7):881-90.
2003: Marianne Nordsmark; Juliette A Loncaster; Christina Aquino-Parsons; Shu-Chuan Chou; Morten Ladekarl; Hanne Havsteen; Jens Lindegaard; Susan E Davidson; Mahesh Varia; Catharine West; Robin Hunter; Jens Overgaard; James Raleigh
Measurements of hypoxia using pimonidazole and polarographic oxygen-sensitive electrodes in human cervix carcinomas.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2003;67(1):35-44.
2003: Cai Grau; Jai Prakash Agarwal; Kaukab Jabeen; Abdul Rab Khan; Sarath Abeyakoon; Tatiana Hadjieva; Ibrahim Wahid; Sedat Turkan; Hideo Tatsuzaki; Ketayun A Dinshaw; Jens Overgaard
Radiotherapy with or without mitomycin c in the treatment of locally advanced head and neck cancer: results of the IAEA multicentre randomised trial.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2003;67(1):17-26.
2003: S Hansen; Jens Overgaard; C Rose; Ann Knoop; Anne-Vibeke Laenkholm; J Andersen; Flemming Brandt Sørensen; P A Andreasen
Independent prognostic value of angiogenesis and the level of plasminogen activator inhibitor type 1 in breast cancer patients.
British journal of cancer 2003;88(1):102-8.
2003: Lars Vendelbo Johansen; Cai Grau; Jens Overgaard
Laryngeal carcinoma--multivariate analysis of prognostic factors in 1252 consecutive patients treated with primary radiotherapy.
Acta oncologica (Stockholm, Sweden) 2003;42(7):771-8.
2003: Anni R Jensen; Jens Peter Garne; Hans H Storm; Marianne Ewertz; Søren Cold; Thor Alvegaard; Jens Overgaard
Stage and survival in breast cancer patients in screened and non-screened Danish and Swedish populations.
Acta oncologica (Stockholm, Sweden) 2003;42(7):701-9.
2003: Anni R Jensen; Hans H Storm; Susanne Møller; Jens Overgaard
Validity and representativity in the Danish Breast Cancer Cooperative Group--a study on protocol allocation and data validity from one county to a multi-centre database.
Acta oncologica (Stockholm, Sweden) 2003;42(3):179-85.
2003: Jonas Hald; Jens Overgaard; Cai Grau
Evaluation of objective measures of smoking status--a prospective clinical study in a group of head and neck cancer patients treated with radiotherapy.
Acta oncologica (Stockholm, Sweden) 2003;42(2):154-9.
2002: Birgitte Vrou Offersen; M M Knap; Niels Marcussen; Michael R Horsman; Stephen Hamilton-Dutoit; Jens Overgaard
Intense inflammation in bladder carcinoma is associated with angiogenesis and indicates good prognosis.
British journal of cancer 2002;87(12):1422-30.
2002: Grethe Harbo; Troels Bundgaard; D Pedersen; Helmer Søgaard; Jens Overgaard
Prognostic indicators for malignant tumours of the parotid gland.
Clinical otolaryngology and allied sciences 2002;27(6):512-6.
2002: Lise Lotte Hansen; Lise Lind Jensen; Constantine Dimitrakakis; Stylianos Michalas; Fred Gilbert; Hugh R K Barber; Jens Overgaard; Iordanis I Arzimanoglou
Allelic imbalance in selected chromosomal regions in ovarian cancer.
Cancer genetics and cytogenetics 2002;139(1):1-8.
2002: Christian Nicolaj Andreassen; Jan Alsner; Jens Overgaard
Does variability in normal tissue reactions after radiotherapy have a genetic basis--where and how to look for it?
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2002;64(2):131-40.
2002: Anni R Jensen; Jens Overgaard; Hans H Storm
Validity of breast cancer in the Danish Cancer Registry. A study based on clinical records from one county in Denmark.
European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP) 2002;11(4):359-64.
2002: Grethe Harbo; Troels Bundgaard; Jens Overgaard; Cai Grau
Comparison of two T-classification systems for sino-nasal carcinoma.
Clinical otolaryngology and allied sciences 2002;27(4):254-9.
2002: Lars Vendelbo Johansen; Cai Grau; Jens Overgaard
Supraglottic carcinoma: patterns of failure and salvage treatment after curatively intended radiotherapy in 410 consecutive patients.
International journal of radiation oncology, biology, physics 2002;53(4):948-58.
2002: Lars Vendelbo Johansen; Cai Grau; Jens Overgaard
Glottic carcinoma--patterns of failure and salvage treatment after curative radiotherapy in 861 consecutive patients.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2002;63(3):257-67.
2002: Birgitte Vrou Offersen; Michael Borre; Flemming Brandt Sørensen; Jens Overgaard
Comparison of methods of microvascular staining and quantification in prostate carcinoma: relevance to prognosis.
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 2002;110(2):177-85.
2002: Birgitte Vrou Offersen; Flemming Brandt Sørensen; Mette Yilmaz; Ann Knoop; Jens Overgaard
Chalkley estimates of angiogenesis in early breast cancer--relevance to prognosis.
Acta oncologica (Stockholm, Sweden) 2002;41(7-8):695-703.
2002: Jørgen Johansen; Jens Overgaard; Carsten Rose; Svend A Engelholm; Carl C Gadeberg; Mogens Kjaer; Claus Kamby; Jens Juul-Christensen; Mogens Blichert-Toft; Marie Overgaard
Cosmetic outcome and breast morbidity in breast-conserving treatment--results from the Danish DBCG-82TM national randomized trial in breast cancer.
Acta oncologica (Stockholm, Sweden) 2002;41(4):369-80.
2002: Lise Bentzen; Susanne Keiding; Michael R Horsman; Tove Grönroos; Søren B Hansen; Jens Overgaard
Assessment of hypoxia in experimental mice tumours by [18F]fluoromisonidazole PET and pO2 electrode measurements. Influence of tumour volume and carbogen breathing.
Acta oncologica (Stockholm, Sweden) 2002;41(3):304-12.
2002: Anni R Jensen; Jan Mainz; Jens Overgaard
Impact of delay on diagnosis and treatment of primary lung cancer.
Acta oncologica (Stockholm, Sweden) 2002;41(2):147-52.
2001: Rumi Murata; Jens Overgaard; Michael R Horsman
Combretastatin A-4 disodium phosphate: a vascular targeting agent that improves that improves the anti-tumor effects of hyperthermia, radiation, and mild thermoradiotherapy.
International journal of radiation oncology, biology, physics 2001;51(4):1018-24.
2001: Rumi Murata; Jens Overgaard; Michael R Horsman
Potentiation of the anti-tumour effect of hyperthermia by combining with the vascular targeting agent 5,6-dimethylxanthenone-4-acetic acid.
International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group 2001;17(6):508-19.
2001: Rumi Murata; Dietmar W Siemann; Jens Overgaard; Michael R Horsman
Improved tumor response by combining radiation and the vascular-damaging drug 5,6-dimethylxanthenone-4-acetic acid.
Radiation research 2001;156(5 Pt 1):503-9.
2001: Rumi Murata; Dietmar W Siemann; Jens Overgaard; Michael R Horsman
Interaction between combretastatin A-4 disodium phosphate and radiation in murine tumors.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2001;60(2):155-61.
2001: Flemming U Nielsen; P Daugaard; Lise Bentzen; Hans Stødkilde-Jørgensen; Jens Overgaard; Michael R Horsman; Ross J Maxwell
Effect of changing tumor oxygenation on glycolytic metabolism in a murine C3H mammary carcinoma assessed by in vivo nuclear magnetic resonance spectroscopy.
Cancer research 2001;61(13):5318-25.
2001: Jan Alsner; S B Sørensen; Jens Overgaard
TP53 mutation is related to poor prognosis after radiotherapy, but not surgery, in squamous cell carcinoma of the head and neck.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2001;59(2):179-85.
2001: Marianne Nordsmark; Jan Alsner; J Keller; Ole Steen Nielsen; Olaf Myhre Jensen; Michael R Horsman; Jens Overgaard
Hypoxia in human soft tissue sarcomas: adverse impact on survival and no association with p53 mutations.
British journal of cancer 2001;84(8):1070-5.
2001: Birgitte Vrou Offersen; P Pfeiffer; Stephen Hamilton-Dutoit; Jens Overgaard
Patterns of angiogenesis in nonsmall-cell lung carcinoma.
Cancer 2001;91(8):1500-9.
2001: Rumi Murata; Jens Overgaard; Michael R Horsman
Comparative effects of combretastatin A-4 disodium phosphate and 5,6-dimethylxanthenone-4-acetic acid on blood perfusion in a murine tumour and normal tissues.
International journal of radiation biology 2001;77(2):195-204.
2001: Marianne Nordsmark; Juliette A Loncaster; Shu-Chuan Chou; Hanne Havsteen; Jens Lindegaard; Susan E Davidson; Mahesh Varia; Catharine West; Robin Hunter; Jens Overgaard; James Raleigh
Invasive oxygen measurements and pimonidazole labeling in human cervix carcinoma.
International journal of radiation oncology, biology, physics 2001;49(2):581-6.
2001: Jan Alsner; Morten Høyer; S B Sørensen; Jens Overgaard
Interaction between potential doubling time and TP53 mutation: predicting radiotherapy outcome in squamous cell carcinoma of the head and neck.
International journal of radiation oncology, biology, physics 2001;49(2):519-25.
2001: Lars Vendelbo Johansen; Cai Grau; Jens Overgaard
Squamous cell carcinoma of the nasopharynx--an analysis of treatment results in 149 consecutive patients.
Acta oncologica (Stockholm, Sweden) 2001;40(7):801-9.
2001: Michael R Horsman; Rumi Murata; Jens Overgaard
Improving local tumor control by combining vascular targeting drugs, mild hyperthermia and radiation.
Acta oncologica (Stockholm, Sweden) 2001;40(4):497-503.
2000: Jan Alsner; Mette Yilmaz; P Guldberg; Lise Lotte Hansen; Jens Overgaard
Heterogeneity in the clinical phenotype of TP53 mutations in breast cancer patients.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(10):3923-31.
2000: Marianne Nordsmark; Jens Overgaard
A confirmatory prognostic study on oxygenation status and loco-regional control in advanced head and neck squamous cell carcinoma treated by radiation therapy.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2000;57(1):39-43.
2000: Michael Borre; B Stausbol-Gron; Jens Overgaard
p53 accumulation associated with bcl-2, the proliferation marker MIB-1 and survival in patients with prostate cancer subjected to watchful waiting.
The Journal of urology 2000;164(3 Pt 1):716-21.
2000: Michael Borre; B Nerstrøm; Jens Overgaard
Association between immunohistochemical expression of vascular endothelial growth factor (VEGF), VEGF-expressing neuroendocrine-differentiated tumor cells, and outcome in prostate cancer patients subjected to watchful waiting.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(5):1882-90.
2000: Lise Bentzen; Susanne Keiding; Michael R Horsman; Lise Falborg; Søren B Hansen; Jens Overgaard
Feasibility of detecting hypoxia in experimental mouse tumours with 18F-fluorinated tracers and positron emission tomography--a study evaluating [18F]Fluoro-2-deoxy-D-glucose.
Acta oncologica (Stockholm, Sweden) 2000;39(5):629-37.
2000: Lars Vendelbo Johansen; Cai Grau; Jens Overgaard
Hypopharyngeal squamous cell carcinoma--treatment results in 138 consecutively admitted patients.
Acta oncologica (Stockholm, Sweden) 2000;39(4):529-36.
2000: Z Kocak; Jens Overgaard
Risk factors of arm lymphedema in breast cancer patients.
Acta oncologica (Stockholm, Sweden) 2000;39(3):389-92.
2000: I Højris; J Andersen; Marie Overgaard; Jens Overgaard
Late treatment-related morbidity in breast cancer patients randomized to postmastectomy radiotherapy and systemic treatment versus systemic treatment alone.
Acta oncologica (Stockholm, Sweden) 2000;39(3):355-72.
2000: J Johansen; Jens Overgaard; Mogens Blichert-Toft; Marie Overgaard
Treatment of morbidity associated with the management of the axilla in breast-conserving therapy.
Acta oncologica (Stockholm, Sweden) 2000;39(3):349-54.
2000: Jens Overgaard; Mette Yilmaz; P Guldberg; Lise Lotte Hansen; Jan Alsner
TP53 mutation is an independent prognostic marker for poor outcome in both node-negative and node-positive breast cancer.
Acta oncologica (Stockholm, Sweden) 2000;39(3):327-33.
2000: Michael R Horsman; Rumi Murata; Tomas Breidahl; Flemming U Nielsen; Ross J Maxwell; H Stødkiled-Jørgensen; Jens Overgaard
Combretastatins novel vascular targeting drugs for improving anti-cancer therapy. Combretastatins and conventional therapy.
Advances in experimental medicine and biology 2000;476():311-23.
2000: J Z Skoczylas; Søren M Bentzen; Marie Overgaard; Jens Overgaard
Time course of radiological lung density changes after postmastectomy radiotherapy.
Acta oncologica (Stockholm, Sweden) 2000;39(2):181-7.
1999: I Højris; Marie Overgaard; Jens Juul Christensen; Jens Overgaard
Morbidity and mortality of ischaemic heart disease in high-risk breast-cancer patients after adjuvant postmastectomy systemic treatment with or without radiotherapy: analysis of DBCG 82b and 82c randomised trials. Radiotherapy Committee of the Danish Breast Cancer Cooperative Group.
Lancet 1999;354(9188):1425-30.
1999: Michael Borre; I B Offersen; B Nerstrøm; Jens Overgaard
[Angiogenesis: prognostic marker in prostatic cancer].
Ugeskrift for laeger 1999;161(25):3832-6.
1999: Flemming U Nielsen; S Topp; Michael R Horsman; Jens Overgaard; Hans Stødkilde-Jørgensen; Ross J Maxwell
Localized in vivo 1H NMR spectroscopy of murine tumours: effect of blood flow reduction.
NMR in biomedicine 1999;12(4):175-83.
1999: Marie Overgaard; Maj-Britt Jensen; Jens Overgaard; P S Hansen; C Rose; Michael Andersson; Claus Kamby; M Kjaer; Carl C Gadeberg; B B Rasmussen; M Blichert-Toft; Henning T Mouridsen
Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial.
Lancet 1999;353(9165):1641-8.
1999: B Stausbøl-Grøn; Søren M Bentzen; K E Jørgensen; Ole Steen Nielsen; T Bundgaard; Jens Overgaard
In vitro radiosensitivity of tumour cells and fibroblasts derived from head and neck carcinomas: mutual relationship and correlation with clinical data.
British journal of cancer 1999;79(7-8):1074-84.
1999: B Stausbøl-Grøn; Jens Overgaard
Relationship between tumour cell in vitro radiosensitivity and clinical outcome after curative radiotherapy for squamous cell carcinoma of the head and neck.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1999;50(1):47-55.
1998: Michael R Horsman; Marianne Nordsmark; Jens Overgaard
Techniques to assess the oxygenation of human tumors. State of the art.
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 1998;174 Suppl 4():2-5.
1998: Michael R Horsman; Eva Ehrnrooth; M Ladekarl; Jens Overgaard
The effect of combretastatin A-4 disodium phosphate in a C3H mouse mammary carcinoma and a variety of murine spontaneous tumors.
International journal of radiation oncology, biology, physics 1998;42(4):895-8.
1998: Michael Borre; Birgitte Vrou Offersen; B Nerstrøm; Jens Overgaard
Microvessel density predicts survival in prostate cancer patients subjected to watchful waiting.
British journal of cancer 1998;78(7):940-4.
1998: Michael Borre; Morten Høyer; B Nerstrøm; Jens Overgaard
DNA ploidy and survival of patients with clinically localized prostate cancer treated without intent to cure.
The Prostate 1998;36(4):244-9.
1998: J Johansen; Christian Streffer; C Fuhrmann; Søren M Bentzen; B Stausbøl-Grøn; Marie Overgaard; Jens Overgaard
Radiosensitivity of normal fibroblasts from breast cancer patients assessed by the micronucleus and colony assays.
International journal of radiation biology 1998;73(6):671-8.
1998: Lise Lotte Hansen; M Yilmaz; Jens Overgaard; J Andersen; Torben A Kruse
Allelic loss of 16q23.2-24.2 is an independent marker of good prognosis in primary breast cancer.
Cancer research 1998;58(10):2166-9.
1998: Michael Borre; S M Bentzen; B Nerstrøm; Jens Overgaard
Tumor cell proliferation and survival in patients with prostate cancer followed expectantly.
The Journal of urology 1998;159(5):1609-14.
1998: Birgitte Vrou Offersen; Michael Borre; Jens Overgaard
Immunohistochemical determination of tumor angiogenesis measured by the maximal microvessel density in human prostate cancer.
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 1998;106(4):463-9.
1998: Michael Borre; Morten Høyer; Flemming Brandt Sørensen; B Nerstrøm; Jens Overgaard
Association between in vivo iododeoxyuridine labeling, MIB-1 expression, malignancy grade and clinical stage in human prostate cancer.
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 1998;106(3):389-95.
1998: L L Hansen; J Andersen; Jens Overgaard; T A Kruse
Molecular genetic analysis of easily accessible breast tumour DNA, purified from tissue left over from hormone receptor measurement.
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 1998;106(3):371-7.
1998: Ann Knoop; P A Andreasen; JA Andersen; S Hansen; Anne-Vibeke Laenkholm; A C Simonsen; J Andersen; Jens Overgaard; C Rose
Prognostic significance of urokinase-type plasminogen activator and plasminogen activator inhibitor-1 in primary breast cancer.
British journal of cancer 1998;77(6):932-40.
1998: Morten Høyer; K Jørgensen; Troels Bundgaard; Lars Vendelbo Johansen; Søren M Bentzen; Marie Overgaard; Olfred Hansen; Helmer Søgaard; Jens Overgaard
Lack of predictive value of potential doubling time and iododeoxyuridine labelling index in radiotherapy of squamous cell carcinoma of the head and neck.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1998;46(2):147-55.
1998: Jens Overgaard; Hanne Sand Hansen; Marie Overgaard; Lars Bastholt; Anne Kiil Berthelsen; Lena Specht; B Lindeløv; K Jørgensen
A randomized double-blind phase III study of nimorazole as a hypoxic radiosensitizer of primary radiotherapy in supraglottic larynx and pharynx carcinoma. Results of the Danish Head and Neck Cancer Study (DAHANCA) Protocol 5-85.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1998;46(2):135-46.
1998: Michael R Horsman; Jan Alsner; Jens Overgaard
The effect of shark cartilage extracts on the growth and metastatic spread of the SCCVII carcinoma.
Acta oncologica (Stockholm, Sweden) 1998;37(5):441-5.
1997: Michael R Horsman; Dietmar W Siemann; D J Chaplin; Jens Overgaard
Nicotinamide as a radiosensitizer in tumours and normal tissues: the importance of drug dose and timing.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1997;45(2):167-74.
1997: A A Khalil; Søren M Bentzen; Jens Overgaard
Steepness of the dose-response curve as a function of volume in an experimental tumor irradiated under ambient or hypoxic conditions.
International journal of radiation oncology, biology, physics 1997;39(4):797-802.
1997: Marie Overgaard; P S Hansen; Jens Overgaard; C Rose; Michael Andersson; F Bach; M Kjaer; Carl C Gadeberg; Henning T Mouridsen; Maj-Britt Jensen; K Zedeler
Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial.
The New England journal of medicine 1997;337(14):949-55.
1997: Michael Borre; B Nerstrøm; Jens Overgaard
The natural history of prostate carcinoma based on a Danish population treated with no intent to cure.
Cancer 1997;80(5):917-28.
1997: Michael Borre; B Nerstrøm; Jens Overgaard
[Prostatic cancer: an expensive dilemma].
Ugeskrift for laeger 1997;159(17):2534-7.
1997: Olfred Hansen; Jens Overgaard; Hanne Sand Hansen; Marie Overgaard; M Höyer; K E Jörgensen; Lars Bastholt; Anne Kiil Berthelsen
Importance of overall treatment time for the outcome of radiotherapy of advanced head and neck carcinoma: dependency on tumor differentiation.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1997;43(1):47-51.
1997: Michael R Horsman; Jens Overgaard
Can mild hyperthermia improve tumour oxygenation?
International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group 1997;13(2):141-7.
1997: Michael Borre; B Nerstrøm; Jens Overgaard
Erythrocyte sedimentation rate--a predictor of malignant potential in early prostate cancer.
Acta oncologica (Stockholm, Sweden) 1997;36(7):689-94.
1997: Michael Borre; B Nerstrøm; Jens Overgaard
The dilemma of prostate cancer--a growing human and economic burden irrespective of treatment strategies.
Acta oncologica (Stockholm, Sweden) 1997;36(7):681-7.
1997: Marianne Nordsmark; J Keller; Ole Steen Nielsen; E Lundorf; Jens Overgaard
Tumour oxygenation assessed by polarographic needle electrodes and bioenergetic status measured by 31P magnetic resonance spectroscopy in human soft tissue tumours.
Acta oncologica (Stockholm, Sweden) 1997;36(6):565-71.
1997: Marianne Nordsmark; Ross J Maxwell; Michael R Horsman; Søren M Bentzen; Jens Overgaard
The effect of hypoxia and hyperoxia on nucleoside triphosphate/inorganic phosphate, pO2 and radiation response in an experimental tumour model.
British journal of cancer 1997;76(11):1432-9.
1997: Grethe Harbo; Cai Grau; Troels Bundgaard; Marie Overgaard; O Elbrønd; Helmer Søgaard; Jens Overgaard
Cancer of the nasal cavity and paranasal sinuses. A clinico-pathological study of 277 patients.
Acta oncologica (Stockholm, Sweden) 1997;36(1):45-50.
1996: Michael R Horsman; L E Sampson; D J Chaplin; Jens Overgaard
The in vivo interaction between flavone acetic acid and hyperthermia.
International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group 1996;12(6):779-89.
1996: Marianne Nordsmark; Marie Overgaard; Jens Overgaard
Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1996;41(1):31-9.
1996: A Safwat; S M Bentzen; Ole Steen Nielsen; H K Mahmoud; Jens Overgaard
Repair capacity of mouse lung after total body irradiation alone or combined with cyclophosphamide.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1996;40(3):249-57.
1996: J Johansen; Søren M Bentzen; Jens Overgaard; Marie Overgaard
Relationship between the in vitro radiosensitivity of skin fibroblasts and the expression of subcutaneous fibrosis, telangiectasia, and skin erythema after radiotherapy.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1996;40(2):101-9.
1996: Søren M Bentzen; J Z Skoczylas; Marie Overgaard; Jens Overgaard
Radiotherapy-related lung fibrosis enhanced by tamoxifen.
Journal of the National Cancer Institute 1996;88(13):918-22.
1996: Marianne Nordsmark; R J Maxwell; P J Wood; I J Stratford; G E Adams; Jens Overgaard; Michael R Horsman
Effect of hydralazine in spontaneous tumours assessed by oxygen electrodes and 31P-magnetic resonance spectroscopy.
The British journal of cancer. Supplement 1996;27():S232-5.
1996: Michael R Horsman; D J Chaplin; S A Hill; S Arnold; D Collingridge; M Radacic; P J Wood; Jens Overgaard
Effect of nitro-L-arginine on blood flow, oxygenation and the activity of hypoxic cell cytotoxins in murine tumours.
The British journal of cancer. Supplement 1996;27():S168-71.
1996: Marianne Nordsmark; Morten Høyer; J Keller; Ole Steen Nielsen; O M Jensen; Jens Overgaard
The relationship between tumor oxygenation and cell proliferation in human soft tissue sarcomas.
International journal of radiation oncology, biology, physics 1996;35(4):701-8.
1996: Olfred Hansen; C Grau; Søren M Bentzen; Jens Overgaard
Repopulation in the SCCVII squamous cell carcinoma assessed by an in vivo-in vitro excision assay.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1996;39(2):137-44.
1996: Søren M Bentzen; J Z Skoczylas; Marie Overgaard; Jens Overgaard; O G Nielsen; E H Madsen
Quantitative assessment of radiation-induced lung changes by computerized optical densitometry of routine chest x-rays.
International journal of radiation oncology, biology, physics 1996;34(2):421-7.
1996: A Safwat; Ole Steen Nielsen; S El-Badawy; Jens Overgaard
Effect of radiation dose rate and cyclophosphamide on pulmonary toxicity after total body irradiation in a mouse model.
International journal of radiation oncology, biology, physics 1996;34(1):85-91.
1996: Jacob Christian Lindegaard; Jens Overgaard; Søren M Bentzen; D Pedersen
Is there a radiobiologic basis for improving the treatment of advanced stage cervical cancer?
Journal of the National Cancer Institute. Monographs 1996;(21):105-12.
1996: P J Wood; Michael R Horsman; A A Khalil; F Steinberg; C Streffer; Jens Overgaard; Ian J Stratford; GE Adams
A comparison of the physiological effects of RSU1069 and RB6145 in the SCCVII murine tumour.
Acta oncologica (Stockholm, Sweden) 1996;35(8):989-94.
1996: Jens Overgaard; D Gonzalez Gonzalez; M C Hulshof; Giorgio Arcangeli; O Dahl; O Mella; S M Bentzen
Hyperthermia as an adjuvant to radiation therapy of recurrent or metastatic malignant melanoma. A multicentre randomized trial by the European Society for Hyperthermic Oncology.
International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group 1996;12(1):3-20.
1995: Michael R Horsman; Marianne Nordsmark; Morten Høyer; Jens Overgaard
Direct evidence that hydralazine can induce hypoxia in both transplanted and spontaneous murine tumours.
British journal of cancer 1995;72(6):1474-8.
1995: B Stausbøl-Grøn; Ole Steen Nielsen; S Møller Bentzen; Jens Overgaard
Selective assessment of in vitro radiosensitivity of tumour cells and fibroblasts from single tumour biopsies using immunocytochemical identification of colonies in the soft agar clonogenic assay.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1995;37(2):87-99.
1995: A Safwat; Ole Steen Nielsen; S el-Badawy; Jens Overgaard
Late renal damage after total body irradiation and bone marrow transplantation in a mouse model: effect of radiation fractionation.
European journal of cancer (Oxford, England : 1990) 1995;31A(6):987-92.
1995: Jens Overgaard; D Gonzalez Gonzalez; M C Hulshof; G Arcangeli; O Dahl; O Mella; S M Bentzen
Randomised trial of hyperthermia as adjuvant to radiotherapy for recurrent or metastatic malignant melanoma. European Society for Hyperthermic Oncology.
Lancet 1995;345(8949):540-3.
1995: Jacob Christian Lindegaard; Ole Steen Nielsen; Jens Overgaard
Effects of step-down and step-up heating on the development of thermotolerance in a C3H mammary carcinoma in vivo.
International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group 1995;11(2):231-9.
1995: A Safwat; Ole Steen Nielsen; H abd el-Bakky; Jens Overgaard
Renal damage after total body irradiation in a mouse model for bone marrow transplantation: effect of radiation dose rate.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1995;34(3):203-9.
1995: L N Salling; Morten Høyer; Jens Overgaard
The effect of castration on tumor growth rate and cell kinetics in hormone sensitive and hormone insensitive rat prostatic adenocarcinomas.
Scandinavian journal of urology and nephrology. Supplementum 1995;172():73-9.
1995: Marianne Nordsmark; C Grau; Michael R Horsman; H S Jörgensen; Jens Overgaard
Relationship between tumour oxygenation, bioenergetic status and radiobiological hypoxia in an experimental model.
Acta oncologica (Stockholm, Sweden) 1995;34(3):329-34.
1995: Michael R Horsman; C Grau; Jens Overgaard
Reoxygenation in a C3H mouse mammary carcinoma. The importance of chronic rather than acute hypoxia.
Acta oncologica (Stockholm, Sweden) 1995;34(3):325-8.
1995: A A Khalil; Michael R Horsman; Jens Overgaard
The importance of determining necrotic fraction when studying the effect of tumour volume on tissue oxygenation.
Acta oncologica (Stockholm, Sweden) 1995;34(3):297-300.
1995: D Pedersen; H Søgaard; Jens Overgaard; S M Bentzen
Prognostic value of pretreatment factors in patients with locally advanced carcinoma of the uterine cervix treated by radiotherapy alone.
Acta oncologica (Stockholm, Sweden) 1995;34(6):787-95.
1995: Michael R Horsman; A A Khalil; D J Chaplin; Jens Overgaard
The ability of nicotinamide to inhibit the growth of a C3H mouse mammary carcinoma.
Acta oncologica (Stockholm, Sweden) 1995;34(3):443-6.
1994: C Grau; Morten Høyer; Jens Overgaard
The in vivo interaction between vincristine and radiation in a C3H mammary carcinoma and the feet of CDF1 mice.
International journal of radiation oncology, biology, physics 1994;30(5):1141-6.
1994: J Johansen; Søren M Bentzen; Jens Overgaard; Marie Overgaard
Evidence for a positive correlation between in vitro radiosensitivity of normal human skin fibroblasts and the occurrence of subcutaneous fibrosis after radiotherapy.
International journal of radiation biology 1994;66(4):407-12.
1994: D Pedersen; S M Bentzen; Jens Overgaard
Early and late radiotherapeutic morbidity in 442 consecutive patients with locally advanced carcinoma of the uterine cervix.
International journal of radiation oncology, biology, physics 1994;29(5):941-52.
1994: Michael R Horsman; K L Christensen; Jens Overgaard
Importance of nicotinamide dose on blood pressure changes in mice and humans.
International journal of radiation oncology, biology, physics 1994;29(3):455-8.
1994: C Grau; Marianne Nordsmark; A A Khalil; Michael R Horsman; Jens Overgaard
Effect of carbon monoxide breathing on hypoxia and radiation response in the SCCVII tumor in vivo.
International journal of radiation oncology, biology, physics 1994;29(3):449-54.
1994: Michael R Horsman; A A Khalil; D W Siemann; C Grau; S A Hill; E M Lynch; D J Chaplin; Jens Overgaard
Relationship between radiobiological hypoxia in tumors and electrode measurements of tumor oxygenation.
International journal of radiation oncology, biology, physics 1994;29(3):439-42.
1994: Morten Høyer; Søren M Bentzen; L N Salling; Jens Overgaard
Influence of sampling time on assessment of potential doubling time.
Cytometry 1994;16(2):144-51.
1994: C Grau; A A Khalil; Marianne Nordsmark; Michael R Horsman; Jens Overgaard
The relationship between carbon monoxide breathing, tumour oxygenation and local tumour control in the C3H mammary carcinoma in vivo.
British journal of cancer 1994;69(1):50-7.
1994: Michael R Horsman; A A Khalil; Marianne Nordsmark; C Grau; Jens Overgaard
Measurement of pO2 in a murine tumour and its correlation with hypoxic fraction.
Advances in experimental medicine and biology 1994;345():493-500.
1994: Michael R Horsman; Marianne Nordsmark; A Khalil; D J Chaplin; Jens Overgaard
Tumour radiosensitization by nicotinamide: is it the result of an improvement in tumour oxygenation?
Advances in experimental medicine and biology 1994;345():403-9.
1994: Marianne Nordsmark; Søren M Bentzen; Jens Overgaard
Measurement of human tumour oxygenation status by a polarographic needle electrode. An analysis of inter- and intratumour heterogeneity.
Acta oncologica (Stockholm, Sweden) 1994;33(4):383-9.
1994: Michael R Horsman; Marianne Nordsmark; A A Khalil; S A Hill; D J Chaplin; D W Siemann; Jens Overgaard
Reducing acute and chronic hypoxia in tumours by combining nicotinamide with carbogen breathing.
Acta oncologica (Stockholm, Sweden) 1994;33(4):371-6.
1994: D Pedersen; S M Bentzen; Jens Overgaard
Continuous or split-course combined external and intracavitary radiotherapy of locally advanced carcinoma of the uterine cervix.
Acta oncologica (Stockholm, Sweden) 1994;33(5):547-55.
1994: Jens Overgaard
Clinical evaluation of nitroimidazoles as modifiers of hypoxia in solid tumors.
Oncology research 1994;6(10-11):509-18.
1994: Michael R Horsman; D W Siemann; Marianne Nordsmark; A A Khalil; Jens Overgaard; D J Chaplin
The combination of nicotinamide and carbogen breathing to improve tumour oxygenation prior to radiation treatment.
Advances in experimental medicine and biology 1994;361():635-42.
1993: Jens Overgaard; M Radacic; D Skaric; V Skaric; Michael R Horsman; Jacob Christian Lindegaard; J Jercic
Use of tetrahydraindazolone dicarboxylic acid (HIDA) to improve the therapeutic effect in vivo of combined cisplatin, heat and radiation treatment.
International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group 1993;9(6):821-30.
1993: Ole Steen Nielsen; A Safwat; Jens Overgaard
The effect of sequence and time interval between cyclophosphamide and total body irradiation on lung and bone marrow damage following bone marrow transplantation in mice.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1993;29(1):51-9.
1993: D Pedersen; S M Bentzen; Jens Overgaard
Reporting radiotherapeutic complications in patients with uterine cervical cancer. The importance of latency and classification system.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1993;28(2):134-41.
1993: Michael R Horsman; A A Khalil; Marianne Nordsmark; C Grau; Jens Overgaard
Relationship between radiobiological hypoxia and direct estimates of tumour oxygenation in a mouse tumour model.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1993;28(1):69-71.
1993: Michael R Horsman; Morten Høyer; D J Honess; I F Dennis; Jens Overgaard
Nicotinamide pharmacokinetics in humans and mice: a comparative assessment and the implications for radiotherapy.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1993;27(2):131-9.
1993: A Safwat; Ole Steen Nielsen; Jens Overgaard
Is kidney the real dose-limiting organ after total body irradiation and bone marrow transplantation?
European journal of cancer (Oxford, England : 1990) 1993;29A(6):929.
1993: M Radacic; Jens Overgaard; D Skaric; V Skaric; Michael R Horsman
Reduction of cisplatinum-induced renal toxicity in mice by tetrahydroindazolonecarboxylic acid (HIDA) [corrected].
Acta oncologica (Stockholm, Sweden) 1993;32(1):53-6.
1993: Søren M Bentzen; Marie Overgaard; Jens Overgaard
Clinical correlations between late normal tissue endpoints after radiotherapy: implications for predictive assays of radiosensitivity.
European journal of cancer (Oxford, England : 1990) 1993;29A(10):1373-6.
1993: Marie Overgaard; Kamma Bertelsen; M Dalmark; Carl C Gadeberg; Hans von der Maase; Jens Overgaard; A Sell
A randomized feasibility study evaluating the effect of radiotherapy alone or combined with 5-fluorouracil in the treatment of locally recurrent or inoperable colorectal carcinoma.
Acta oncologica (Stockholm, Sweden) 1993;32(5):547-53.
1992: Søren M Bentzen; F Lundbeck; L L Christensen; Jens Overgaard
Fractionation sensitivity and latency of late radiation injury to the mouse urinary bladder.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1992;25(4):301-7.
1992: C Grau; K Møller; M Overgaard; Jens Overgaard; O Elbrønd
Auditory brain stem responses in patients after radiation therapy for nasopharyngeal carcinoma.
Cancer 1992;70(10):2396-401.
1992: D Pedersen; Jens Overgaard; H Søgaard; O Elbrønd; Marie Overgaard
Malignant parotid tumors in 110 consecutive patients: treatment results and prognosis.
The Laryngoscope 1992;102(9):1064-9.
1992: Michael R Horsman; Jens Overgaard
BW12C-induced changes in haemoglobin-oxygen affinity in mice and its influence on the radiation response of a C3H mouse mammary carcinoma.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1992;25(1):43-8.
1992: F Lundbeck; Jens Overgaard
Early and late changes in the normal mouse bladder reservoir function due to irradiation and cis-DDP.
British journal of cancer 1992;66(1):99-105.
1992: Troels Bundgaard; F B Sørensen; Michael Gaihede; H Søgaard; Jens Overgaard
Stereologic, histopathologic, flow cytometric, and clinical parameters in the prognostic evaluation of 74 patients with intraoral squamous cell carcinomas.
Cancer 1992;70(1):1-13.
1992: Michael R Horsman; K L Christensen; Jens Overgaard
Relationship between the hydralazine-induced changes in murine tumor blood supply and mouse blood pressure.
International journal of radiation oncology, biology, physics 1992;22(3):455-8.
1992: C Grau; Michael R Horsman; Jens Overgaard
Influence of carboxyhemoglobin level on tumor growth, blood flow, and radiation response in an experimental model.
International journal of radiation oncology, biology, physics 1992;22(3):421-4.
1992: C Grau; Michael R Horsman; Jens Overgaard
Improving the radiation response in a C3H mouse mammary carcinoma by normobaric oxygen or carbogen breathing.
International journal of radiation oncology, biology, physics 1992;22(3):415-9.
1992: Jens Overgaard; J E Nielsen; C Grau
Effect of carboxyhemoglobin on tumor oxygen unloading capacity in patients with squamous cell carcinoma of the head and neck.
International journal of radiation oncology, biology, physics 1992;22(3):407-10.
1992: Søren M Bentzen; I Balslev; M Pedersen; P S Teglbjaerg; F Hanberg-Sørensen; J Bone; N O Jacobsen; A Sell; Jens Overgaard; Kamma Bertelsen
Time to loco-regional recurrence after resection of Dukes' B and C colorectal cancer with or without adjuvant postoperative radiotherapy. A multivariate regression analysis.
British journal of cancer 1992;65(1):102-7.
1992: H S Mao; C Grau; Jens Overgaard
Interaction of misonidazole, hyperthermia, and irradiation in a C3H mammary carcinoma and its surrounding skin in vivo.
International journal of radiation oncology, biology, physics 1992;22(1):115-22.
1992: Jacob Christian Lindegaard; M Radacic; A A Khalil; Michael R Horsman; Jens Overgaard
Cisplatin and hyperthermia treatment of a C3H mammary carcinoma in vivo. Importance of sequence, interval, drug dose, and temperature.
Acta oncologica (Stockholm, Sweden) 1992;31(3):347-51.
1992: Michael R Horsman; Paul E.G. Kristjansen; M Mizuno; K L Christensen; D J Chaplin; B Quistorff; Jens Overgaard
Biochemical and physiological changes induced by nicotinamide in a C3H mouse mammary carcinoma and CDF1 mice.
International journal of radiation oncology, biology, physics 1992;22(3):451-4.
1992: M R Horsman; Jens Overgaard
Overcoming tumour radiation resistance resulting from acute hypoxia.
European journal of cancer (Oxford, England : 1990) 1992;28A(4-5):717-8.
1991: Jacob Christian Lindegaard; C Grau; Jens Overgaard
Effect of step-down heating on the interaction between heat and radiation in a C3H mammary carcinoma in vivo.
International journal of radiation biology 1991;60(4):707-21.
1991: C Grau; K Møller; Marie Overgaard; Jens Overgaard; O Elbrønd
Sensori-neural hearing loss in patients treated with irradiation for nasopharyngeal carcinoma.
International journal of radiation oncology, biology, physics 1991;21(3):723-8.
1991: M R Horsman; D J Chaplin; Jens Overgaard
The effect of combining flavone acetic acid and hyperthermia on the growth of a C3H mammary carcinoma in vivo.
International journal of radiation biology 1991;60(1-2):385-8.
1991: Søren M Bentzen; L V Johansen; Jens Overgaard; H D Thames
Clinical radiobiology of squamous cell carcinoma of the oropharynx.
International journal of radiation oncology, biology, physics 1991;20(6):1197-206.
1991: Jacob Christian Lindegaard; Ole Steen Nielsen; Jens Overgaard
A comparison between the effect of step-down heating in a tumour and a normal tissue in vivo.
International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group 1991;7(3):519-26.
1991: C Grau; Jens Overgaard
Radiosensitizing and cytotoxic properties of mitomycin C in a C3H mouse mammary carcinoma in vivo.
International journal of radiation oncology, biology, physics 1991;20(2):265-9.
1991: Jens Overgaard; M M Radacic; C Grau
Interaction of hyperthermia and cis-diamminedichloroplatinum(II) alone or combined with radiation in a C3H mammary carcinoma in vivo.
Cancer research 1991;51(2):707-11.
1991: Jens Overgaard; H Sand Hansen; B Lindeløv; Marie Overgaard; K Jørgensen; B Rasmusson; Anne Kiil Berthelsen
Nimorazole as a hypoxic radiosensitizer in the treatment of supraglottic larynx and pharynx carcinoma. First report from the Danish Head and Neck Cancer Study (DAHANCA) protocol 5-85.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1991;20 Suppl 1():143-9.
1991: Jens Overgaard; C Grau; Jacob Christian Lindegaard; Michael R Horsman
The potential of using hyperthermia to eliminate radioresistant hypoxic cells.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1991;20 Suppl 1():113-6.
1991: R V Fisker; Michael R Horsman; Jens Overgaard
Hydralazine-induced changes in tissue perfusion and radiation response in a C3H mammary carcinoma and mouse normal tissues.
Acta oncologica (Stockholm, Sweden) 1991;30(5):641-7.
1991: Michael R Horsman; D J Chaplin; Jens Overgaard
The use of blood flow modifiers to improve the treatment response of solid tumors.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1991;20 Suppl 1():47-52.
1990: Michael R Horsman; D J Chaplin; Jens Overgaard
Combination of nicotinamide and hyperthermia to eliminate radioresistant chronically and acutely hypoxic tumor cells.
Cancer research 1990;50(23):7430-6.
1990: L V Johansen; Jens Overgaard; Marie Overgaard; N Birkler; A Fisker
Squamous cell carcinoma of the oropharynx: an analysis of 213 consecutive patients scheduled for primary radiotherapy.
The Laryngoscope 1990;100(9):985-90.
1990: L V Johansen; Jens Overgaard; M Hjelm-Hansen; C C Gadeberg
Primary radiotherapy of T1 squamous cell carcinoma of the larynx: analysis of 478 patients treated from 1963 to 1985.
International journal of radiation oncology, biology, physics 1990;18(6):1307-13.
1990: Jacob Christian Lindegaard; Jens Overgaard
Step-down heating in a C3H mammary carcinoma in vivo: effects of varying the time and temperature of the sensitizing treatment.
International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group 1990;6(3):607-17.
1990: Jens Overgaard; M Matsui
Effect of radiation on glucose absorption in the mouse jejunum in vivo.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1990;18(1):71-7.
1990: Søren M Bentzen; I Balslev; M Pedersen; P S Teglbjaerg; F Hanberg-Sørensen; J Bone; N O Jacobsen; A Sell; Jens Overgaard; Kamma Bertelsen
Blood transfusion and prognosis in Dukes' B and C colorectal cancer.
European journal of cancer (Oxford, England : 1990) 1990;26(4):457-63.
1990: C Grau; Søren M Bentzen; Jens Overgaard
Cytotoxic effect of misonidazole and cyclophosphamide on aerobic and hypoxic cells in a C3H mammary carcinoma in vivo.
British journal of cancer 1990;61(1):61-4.
1990: C Grau; C Zachariae; H S Mao; Jens Overgaard
The in vivo response of a C3H mammary carcinoma to treatment with misonidazole, cyclophosphamide and radiation.
Acta oncologica (Stockholm, Sweden) 1990;29(6):769-74.
1990: K L Christensen; Michael R Horsman; Jens Overgaard
Invasive blood pressure measurements in restrained but non-anaesthetized mice.
In vivo (Athens, Greece) 1990;4(1):13-6.
1989: Jens Overgaard
Sensitization of hypoxic tumour cells--clinical experience.
International journal of radiation biology 1989;56(5):801-11.
1989: F Lundbeck; N Ulsø; Jens Overgaard
Cystometric evaluation of early and late irradiation damage to the mouse urinary bladder.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1989;15(4):383-92.
1989: Michael R Horsman; P V Hansen; Jens Overgaard
Radiosensitization by nicotinamide in tumors and normal tissues: the importance of tissue oxygenation status.
International journal of radiation oncology, biology, physics 1989;16(5):1273-6.
1989: I Balslev; M Pedersen; P S Teglbjaerg; F H Srensen; J Boné; N O Jacobsen; Jens Overgaard; A Sell; Kamma Bertelsen; C Fenger
[Prognosis in synchronous liver metastasis from colorectal cancer. A multicenter study of patients with cancer of the rectum and cancer of the rectosigmoid colon].
Ugeskrift for laeger 1989;151(17):1045-8.
1989: Jens Overgaard; Søren M Bentzen; P Kolstad; K Kjoerstad; M Davy; K Bertelsen; M Mäntyla; B Frankendal; A Skryten; I Löftquist
Misonidazole combined with radiotherapy in the treatment of carcinoma of the uterine cervix.
International journal of radiation oncology, biology, physics 1989;16(4):1069-72.
1989: Jens Overgaard; Hanne Sand Hansen; A P Andersen; M Hjelm-Hansen; K Jørgensen; E Sandberg; Anne Kiil Berthelsen; R Hammer; M Pedersen
Misonidazole combined with split-course radiotherapy in the treatment of invasive carcinoma of larynx and pharynx: report from the DAHANCA 2 study.
International journal of radiation oncology, biology, physics 1989;16(4):1065-8.
1989: Michael R Horsman; K L Christensen; Jens Overgaard
Hydralazine-induced enhancement of hyperthermic damage in a C3H mammary carcinoma in vivo.
International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group 1989;5(2):123-36.
1989: Jens Overgaard
The current and potential role of hyperthermia in radiotherapy.
International journal of radiation oncology, biology, physics 1989;16(3):535-49.
1989: Michael R Horsman; Jens Overgaard; K L Christensen; M J Trotter; D J Chaplin
Mechanism for the reduction of tumour hypoxia by nicotinamide and the clinical relevance for radiotherapy.
Biomedica biochimica acta 1989;48(2-3):S251-4.
1988: C Grau; Jens Overgaard
Effect of cancer chemotherapy on the hypoxic fraction of a solid tumor measured using a local tumor control assay.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1988;13(4):301-9.
1988: Ole Steen Nielsen; Hans von der Maase; Jens Overgaard
Effect of combined 5-fluorouracil and radiation on murine hematopoietic tissue.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1988;13(2):145-52.
1988: I Balslev; M Pedersen; P S Teglbjaerg; F H Sørensen; J Boné; N O Jacobsen; Jens Overgaard; A Sell; Kamma Bertelsen; E Hage
[Postoperative radiotherapy in cancer of the rectum and rectosigmoid. A prospective randomized multicenter study].
Ugeskrift for laeger 1988;150(33):1958-61.
1988: Søren M Bentzen; I Balslev; M Pedersen; P S Teglbjaerg; F Hanberg-Soerensen; J Bone; N O Jacobsen; Jens Overgaard; A Sell; Kamma Bertelsen
A regression analysis of prognostic factors after resection of Dukes' B and C carcinoma of the rectum and rectosigmoid. Does post-operative radiotherapy change the prognosis?
British journal of cancer 1988;58(2):195-201.
1988: Jacob Christian Lindegaard; Jens Overgaard
Effect of step-down heating on hyperthermic radiosensitization in an experimental tumor and a normal tissue in vivo.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1988;11(2):143-51.
1988: Jens Overgaard; M Hjelm-Hansen; L V Johansen; A P Andersen
Comparison of conventional and split-course radiotherapy as primary treatment in carcinoma of the larynx.
Acta oncologica (Stockholm, Sweden) 1988;27(2):147-52.
1988: Giorgio Arcangeli; Jens Overgaard; D Gonzalez Gonzalez; P N Shrivastava
International Clinical Trials in Radiation Oncology. Hyperthermia trials.
International journal of radiation oncology, biology, physics 1988;14 Suppl 1():S93-109.
1987: Jens Overgaard; Marie Overgaard
Hyperthermia as an adjuvant to radiotherapy in the treatment of malignant melanoma.
International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group 1987;3(6):483-501.
1987: Jens Overgaard
Some problems related to the clinical use of thermal isoeffect doses.
International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group 1987;3(4):329-36.
1987: Hanne Sand Hansen; J Rygård; A P Andersen; J Munck-Hansen; K Jørgensen; Jens Overgaard; E Sandberg; M H Hansen
Bleomycin, methotrexate and vincristine before irradiation of stage III and IV laryngeal and pharyngeal squamous cell carcinoma. A study initiated by the Danish Society of Head and Neck Cancer.
Acta oncologica (Stockholm, Sweden) 1987;26(1):13-8.
1986: I Balslev; M Pedersen; P S Teglbjaerg; F Hanberg-Soerensen; J Bone; N O Jacobsen; Jens Overgaard; A Sell; Kamma Bertelsen; E Hage
Postoperative radiotherapy in Dukes' B and C carcinoma of the rectum and rectosigmoid. A randomized multicenter study.
Cancer 1986;58(1):22-8.
1982: I Balslev; M Pedersen; P S Teglbjaerg; F Hanberg-Sørensen; J Bone; N O Jacobsen; Jens Overgaard; A Sell; Kamma Bertelsen; E Hage; L Hansen; O Kronborg; H Høstrup; B Nørgaard-Pedersen
Postoperative radiotherapy in rectosigmoid cancer Dukes' B and C: interim report from a randomized multicentre study.
British journal of cancer 1982;46(4):551-6.